Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record

Author's Avatar
May 16, 2023

Validated Nanoemulsion Capabilities Are Transformative Across Multiple Major Markets, New $1.5M Contract, New Manufacturing Facility, and Reduced Cash Burn Set Stage for Expected Strong FY 2023